by healthadvances Posted on January 15, 2021 Google Has Officially Acquired Fitbit. Now What? Read More
by healthadvances Posted on September 24, 2020October 22, 2020 When Off-Label is Your Biggest Competition: Rituximab in Autoimmune Diseases Read More
by healthadvances Posted on September 18, 2020 How COVID-19 Testing Demand Threw off Thermo Fisher’s Acquisition of Qiagen Read More
by healthadvances Posted on September 15, 2020 Hong Kong Exchange: Nurturing China’s Biotech Valley Read More
by healthadvances Posted on August 26, 2020August 26, 2020 eBook: Biopharma in the COVID-19 World Read More
by healthadvances Posted on August 17, 2020 Against All Odds: Can Covid-19 Usher in a New Era in International Public Health Cooperation? Read More
by healthadvances Posted on July 30, 2020January 13, 2021 Value Creation in Molecular Diagnostics: A Game of Luck or Skill? Read More
by healthadvances Posted on July 16, 2020July 17, 2020 Is Cardiovascular R&D Ready for a Comeback? Read More
by healthadvances Posted on July 16, 2020July 16, 2020 Demystifying SARS-CoV-2 Testing for COVID-19 (Third Edition – Part 1: Updates and Trends) Read More
by healthadvances Posted on June 4, 2020 SARS-CoV-2 Landscape of Repurposed Drug Trials and Key Lessons for the Future Read More
by healthadvances Posted on May 14, 2020May 14, 2020 COVID-19 Impact on Rare Disease Patients and Manufacturers Read More
by healthadvances Posted on May 13, 2020 Protective Antibody Therapy: Preventing Future COVID-19 Outbreaks Read More
by healthadvances Posted on May 12, 2020 Launch Costs—Spend Wisely: Analysis by Order of Entry Read More
by healthadvances Posted on May 8, 2020 Demystifying SARS-CoV-2 Testing for COVID-19 (Second Edition) Read More
by healthadvances Posted on May 8, 2020 Demystifying SARS-CoV-2 Testing for COVID-19 (First Edition) Read More
by healthadvances Posted on May 8, 2020 How COVID-19 is Accelerating Telemedicine Adoption in Asia Pacific Read More
by healthadvances Posted on May 6, 2020 The Changing Fortunes of Telemedicine in Europe – Past, Present, and Future beyond COVID-19 Read More
by healthadvances Posted on May 4, 2020 Biopharma Sales Resilience through Economic Recession Read More
